Search results for "3’"

showing 10 items of 11 documents

Pyrido[2’,3’:4,5]pyrrolo[2,1-d][1,2,3,5]tetrazine-4(3H)-ones, a new class of temozolomide heteroanalogues

2009

Twelve derivatives of new ring system pyrido[2’,3’:4,5]pyrrolo[2,1-d][1,2,3,5]tetrazine were prepared in good yields by reaction of 2-diazo-3-ethoxycarbonyl-pyrrolo[3,2-b]pyridine with alkyl- or aryl-isocyanates. Nine derivatives, screened by the National Cancer Institute (Bethesda, MD) for the in vitro one dose primary anticancer assay against a panel of about 60 human tumor cell lines, showed no significant activity.

3Stereochemistry21-d][1Temozolomide Mitozolomide; pyrrolo[2; 1-d][1; 2; 3; 5]tetrazinones; Antitumor activity; pyrido[2’; 3’:4; 5]pyrrolo[2; 1-d][1; 2; 3; 5]tetrazinesTemozolomide MitozolomideRing (chemistry)Medicinal chemistryD-1Tetrazinechemistry.chemical_compoundpyrido[2’PyridineAlkylchemistry.chemical_classification5]tetrazinonesOrganic Chemistrypyrrolo[23’:4Antitumor activity pyrido[2’3’:45]pyrrolo[21-d][1235]tetrazinesSettore CHIM/08 - Chimica Farmaceuticachemistry5]pyrrolo[2Microwave irradiationTemozolomide Mitozolomide pyrrolo[21-d][1235]tetrazinoneAntitumor activity5]tetrazinesArkivoc
researchProduct

An improvement of ComiR algorithm for microRNA target prediction by exploiting coding region sequences of mRNAs

2020

AbstractMicroRNA are small non-coding RNAs that post-transcriptionally regulate the expression levels of messenger RNAs. MicroRNA regulation activity depends on the recognition of binding sites located on mRNA molecules. ComiR is a web tool realized to predict the targets of a set of microRNAs, starting from their expression profile. ComiR was trained with the information regarding binding sites in the 3’utr region, by using a reliable dataset containing the targets of endogenously expressed microRNA in D. melanogaster S2 cells. This dataset was obtained by comparing the results from two different experimental approaches, i.e., inhibition, and immunoprecipitation of the AGO1 protein--a comp…

AGO1ImmunoprecipitationComputer sciencelcsh:Computer applications to medicine. Medical informaticsBiochemistryOpen Reading Frames03 medical and health sciences0302 clinical medicineStructural BiologymicroRNAMelanogasterAnimalsHumansCoding regionGene silencing3'UTRRNA MessengerBinding sitelcsh:QH301-705.5Molecular Biology030304 developmental biology0303 health sciencesMessenger RNAbiologyThree prime untranslated regionResearchApplied MathematicsmicroRNA target predictionbiology.organism_classificationComputer Science Applications3’UTRMicroRNAsDrosophila melanogasterlcsh:Biology (General)Coding regionlcsh:R858-859.7DNA microarrayDrosophila melanogasterAlgorithmAlgorithms030217 neurology & neurosurgeryBMC Bioinformatics
researchProduct

Nuovi inibitori di Aurora chinasi A come target biologico coinvolto nei processi carcinogenici

2011

Identificando Aurora chinasi A come target elettivo per l’inibizione dell’espansione tumorale è stato sfruttato l’approccio computazionale per effettuare un virtual screening su una libreria “in house” di strutture molecolari. L’analisi dei dati computazionali ha permesso di identificare nei derivati della serie pirido[3’,2’:4,5]furo[3,2-d]-1,2,3-triazin-4(3H)one di tipo 3 nuovi composti a potenziale attività inibitoria sul sito ATP-asico di Aurora chinasi A. La sintesi del sistema triciclico-eteroaromatico 3 prevede la diazotazione della 3-amino-furopiridina 1 e conseguente reazione di copulazione con una serie di ammine primarie opportunamente scelte, permettendo l’isolamento delle 3-tria…

Aurora chinasi A antitumorale pirido[3’2’:45]furo[32-d]-123-triazin-4(3H)one triazeniSettore CHIM/08 - Chimica Farmaceutica
researchProduct

Peroksīdu noteikšana ar eksprestestu metodi

2017

Peroksīdu noteikšana ar eksprestestu metodi. Bruņeniece A., darba vadītājs Dr. ķīm. docents Ģībietis J. Bakalaura darbs, 44 lappuses, 10 tabulas, 26 attēli, 23 literatūras avoti. Latviešu valodā. Darbā apskatītas dažādas ūdeņraža peroksīda un peroksietiķskābes kvantitatīvās noteikšanas metodes. Veikta ITS firmas ekprestesta „Water-Works” teststrēmeļu kalibrēšana. Eksperimentāli izpētīta jonu spēka, pH un organiskā šķīdinātāja ietekme uz teststrēmeļu darbību. Iegūti kalibrēšanas grafiki un izveidotas krāsu standartskalas, izmantojot spektrofotometru – kolorimetru AvaMouse Avantes, kā arī izpētītа teststrēmeļu piеmērotība peroksīdu koncentrācijаs noteikšanаi atšķirīgās vidēs. Iegūtie rezultāt…

EKSPRESTESTIŪDEŅRAŽA PEROKSĪDSPEROKSIETIĶSKĀBE33’55’ – TETRAMETILBENZIDĪNS (TMB)KOLORIMETRIJAĶīmija
researchProduct

Synthesis and antiproliferative activity of new derivatives containing the polycyclic system 5,7:7,13-dimethanopyrazolo[3,4-b]pyrazolo[3’,4’:2,3]azep…

2013

The reaction under reflux between 1-phenyl-3-R-5-methylaminopyrazoles and 2,5-hexanedione lead to 5,7:7,13-dimethanopyrazolo[3,4-b]pyrazolo[3′,4′:2,3]azepino[4,5-f]azocine derivatives 3b–g. These unusual molecules show the structural complexity of many biologically active natural products and are endowed with the chemical diversity that is required in drug discovery. The compounds 3b,e were reduced by hydrogen in the presence of Palladium on activated charcoal to give the dihydro derivatives 5b,e. Compounds 3b–f and 5b,e were selected by the NCI to evaluate their in vitro antiproliferative activity against 60 human cell lines derived from nine clinically isolated cancer types (leukaemia, lu…

Models MolecularStereochemistryAntineoplastic AgentsHL-60 CellsHeterocyclic Compounds 4 or More RingsDephosphorylationchemistry.chemical_compoundStructure-Activity RelationshipCell Line TumorSettore BIO/10 - BiochimicaDrug DiscoverymedicineMoleculeHumansAzocinePolycyclic CompoundsCell ProliferationPharmacologyDose-Response Relationship DrugMolecular StructureDrug discoveryOrganic ChemistryCell CycleCancerBiological activityGeneral MedicineCell cyclemedicine.diseaseSettore CHIM/08 - Chimica FarmaceuticaIn vitrochemistryMCF-7 Cells57:713-dimethanopyrazolo[34-b]pyrazolo[3’4’:23]azepino[45-f]azocine derivatives antiproliferative activity G0-G1 arrest pRbDrug Screening Assays AntitumorK562 Cells
researchProduct

The Reactivity of 4’-Substituted Spiro[Isoindole-1,3’-pyrazoles] Derivatives: Substitution/Elimination Reactions and Access to Biaryl Derivatives

2017

This paper describes aspects of the chemistry of 4’-substituted spiro [indole-1,3’-pyrazoles]. These compounds underwent substitution and/or elimination reactions to afford some new spiro- as well as biaryl derivatives of potential pharmaceutical relevance. Mechanistic considerations are discussed as well.

Pharmacologychemistry.chemical_compoundElimination reaction4’-substituted spiro [indole-13’-pyrazoles] elimination reactions biaryl derivatives Mechanistic considerationschemistryOrganic ChemistrySubstitution (logic)Reactivity (chemistry)Settore CHIM/06 - Chimica OrganicaIsoindoleSettore CHIM/08 - Chimica FarmaceuticaCombinatorial chemistryAnalytical ChemistryHETEROCYCLES
researchProduct

Synthesis, benzodiazepine receptor binding and molecular modelling of isochromeno[4,3-c]pyrazol-5(1H)-one derivatives

2012

Abstract A series of isochromeno[4,3-c]pyrazole-5(1H)-one derivatives 7b–h were prepared and tested at 10 μM for their ability to displace specific [3H]flunitrazepam from bovine brain membranes. The substitution pattern of the above derivatives was shown to influence the receptor affinity. The most active compound of the series was 7e, showing a 54% inhibition of [3H]flunitrazepam binding. Compounds 7a–d,i were compared with the known isomers chromeno[4,3-c]pyrazole-4(1H)-ones 14a–d,i, showing that the isochromene/chromene isomerism influences the activity.

StereochemistryProtein ConformationChemistry Techniques SyntheticIsochromeno[43-c]pirazoles Dihydrospiro[isoindole-13’-pyrazol]-3(2H)- ones Benzodiazepine receptorDrug DiscoverymedicineAnimalsHumansBenzopyransReceptorBenzodiazepine receptor bindingPharmacologyChemistryOrganic ChemistryGeneral MedicineReceptors GABA-ASettore CHIM/08 - Chimica FarmaceuticaMolecular Docking SimulationMembraneBovine brainActive compoundPyrazolesCattleFlunitrazepam bindingFlunitrazepammedicine.drugProtein Binding
researchProduct

Etude du rôle du récepteur nucléaire CAR, Constitutive Androstane Receptor, dans le métabolisme des lipides et la susceptibilité à l'athérosclérose

2011

The Constitutive Androstane Receptor (CAR) belongs to the subfamily of nuclear receptors NR1. Initially described as an orphan receptor, CAR is activated by a large number of exogenous molecules and acts as a xenosensor. The activation of CAR by these ligands stimulates transcription of phase I, II and III enzymes required for the detoxification and elimination of xenobiotics. Furthermore CAR is also involved in the metabolism of endogenous molecules such as bile acids, bilirubin or thyroid hormones. CAR has recently been the subject of numerous independent studies that have highlighted his involvement in major metabolic pathways including gluconeogenesis, lipogenesis and lipoprotein metabo…

[SDV.SA]Life Sciences [q-bio]/Agricultural sciencesAthérosclérose[SDV.SA] Life Sciences [q-bio]/Agricultural sciences5[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyVLDL récepteur3’AtherosclerosisAcides biliaires5'-Tetrachloro-1Bile acids4-bis(pyridyloxy)benzene)(35’-Tétrachloro-1[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyCAR (Constitutive Androstane Receptor)3'TCPOBOP (3TriglycéridesVLDL receptor[ SDV.SA ] Life Sciences [q-bio]/Agricultural sciences[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyTriglycerides
researchProduct

A ceRNA analysis on LMNA gene focusing on the Hutchinson-Gilford progeria syndrome

2013

Background: Hutchinson-Gilford progeria syndrome is a rare dominant human disease of genetic origin. The average life expectancy is about 20 years, patients’ life quality is still very poor and no efficient therapy has yet been developed. It is caused by mutation of the LMNA gene, which results in accumulation in the nuclear membrane of a particular splicing form of Lamin-A called progerin. The mechanism by which progerin perturbs cellular homeostasis and leads to the symptoms is still under debate. Micro-RNAs are able to negatively regulate transcription by coupling with the 3’ UnTranslated Region of messenger RNAs. Several Micro-RNAs recognize the same 3’ UnTranslated Region and each Micr…

congenital hereditary and neonatal diseases and abnormalitiesCandidate geneCeRNA Hutchinson-Gilford Progeria LMNA Lamin-A 3’ UTR MiRNALMNACellular homeostasisHealth InformaticsLamin-ABiologySettore MED/13 - EndocrinologiaLMNAProgeriaCeRNAmedicineHutchinson-GilfordGeneticsProgeriaintegumentary systemCompeting endogenous RNAThree prime untranslated regionResearchnutritional and metabolic diseasesmedicine.diseaseProgerinSettore BIO/18 - GeneticaRNA splicing3’ UTRMiRNAJournal of Clinical Bioinformatics
researchProduct

Complessi di Platinum(II): sintesi, studi di DNA-binding e loro attività antitumorale in vitro

2013

Con lo scopo di trovare nuovi analoghi del Cis-DDP (cis-diammino dicloro platino(II)) nuovi complessi del platino sono stati sintetizzati, caratterizzati e ne è stata studiata l’attività antitumorale in vitro [1]. Recentemente sono stati preparati complessi con metalli del quarto periodo di transizione con entrambi i leganti, dipirido[3,2-a:2’,3’-c]fenazina (dppz) e glicinato (gly) [2]. I composti di nuova sintesi vengono generalmente caratterizzati attraverso parecchie tecniche analitiche incluso la cristallografia a raggi-X e la loro attività antitumorale viene testata su un vasto pannello di linee cellulari umane [1,2]. Le proprietà biologiche spesso sono correlate alla loro interazione …

dipirido[32-a:2’3’-c]fenazina (dppz)Complessi di Pt(II)glicinato (gly)
researchProduct